Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Targeting the PAC1 receptor for neurological and metabolic disorders
C Liao, MP de Molliens, ST Schneebeli… - Current topics in …, 2019 - ingentaconnect.com
The pituitary adenylate cyclase-activating polypeptide (PACAP)-selective PAC1 receptor
(PAC1R, ADCYAP1R1) is a member of the vasoactive intestinal peptide (VIP)/secretin …
(PAC1R, ADCYAP1R1) is a member of the vasoactive intestinal peptide (VIP)/secretin …
PACAP and its receptors in cranial arteries and mast cells
I Jansen-Olesen, S Hougaard Pedersen - The Journal of Headache and …, 2018 - Springer
Background In migraineurs pituitary adenylate cyclase activating peptide1–38 (PACAP1–
38) is a potent migraine provoking substance and the accompanying long lasting flushing …
38) is a potent migraine provoking substance and the accompanying long lasting flushing …
Alternative routes of administration of the neuroprotective pituitary adenylate cyclase activating polypeptide
D Reglodi, T Atlasz, A Jungling, E Szabo… - Current …, 2018 - benthamdirect.com
Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide with diverse
actions, including strong neurotrophic and neuroprotective effects. The aim of our present …
actions, including strong neurotrophic and neuroprotective effects. The aim of our present …